Literature DB >> 11182083

Forward signaling mediated by ephrin-B3 prevents contralateral corticospinal axons from recrossing the spinal cord midline.

N Yokoyama1, M I Romero, C A Cowan, P Galvan, F Helmbacher, P Charnay, L F Parada, M Henkemeyer.   

Abstract

To investigate Eph-ephrin bidirectional signaling, a series of mutations were generated in the ephrin-B3 locus. The absence of both forward and reverse signaling resulted in mice with mirror movements as typified by a hopping locomotion. The corticospinal tract was defective as axons failed to respect the midline boundary of the spinal cord and bilaterally innervated both contralateral and ipsilateral motor neuron populations. A second mutation that expresses a truncated ephrin-B3 protein lacking its cytoplasmic domain did not lead to hopping, indicating that reverse signaling is not required for corticospinal innervation. Ephrin-B3 is concentrated at the spinal cord midline, while one of its receptors, EphA4, is expressed in postnatal corticospinal neurons as their fibers pathfind down the contralateral spinal cord. Our data indicate ephrin-B3 functions as a midline-anchored repellent to stimulate forward signaling in EphA4-expressing axons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11182083     DOI: 10.1016/s0896-6273(01)00182-9

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  76 in total

1.  Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.

Authors:  S Elowe; S J Holland; S Kulkarni; T Pawson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury.

Authors:  Philip Duffy; Xingxing Wang; Chad S Siegel; Chad S Seigel; Nathan Tu; Mark Henkemeyer; William B J Cafferty; Stephen M Strittmatter
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

3.  Synaptic patterning of left-right alternation in a computational model of the rodent hindlimb central pattern generator.

Authors:  William Erik Sherwood; Ronald Harris-Warrick; John Guckenheimer
Journal:  J Comput Neurosci       Date:  2010-07-20       Impact factor: 1.621

Review 4.  The role of Eph receptors in lens function and disease.

Authors:  Alexander I Son; Jeong Eun Park; RenPing Zhou
Journal:  Sci China Life Sci       Date:  2012-05-27       Impact factor: 6.038

Review 5.  Axon Guidance Molecules and Neural Circuit Remodeling After Spinal Cord Injury.

Authors:  Edmund R Hollis
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

6.  Variable laterality of corticospinal tract axons that regenerate after spinal cord injury as a result of PTEN deletion or knock-down.

Authors:  Rafer Willenberg; Katherine Zukor; Kai Liu; Zhigang He; Oswald Steward
Journal:  J Comp Neurol       Date:  2016-03-09       Impact factor: 3.215

7.  EphB receptors and ephrin-B3 regulate axon guidance at the ventral midline of the embryonic mouse spinal cord.

Authors:  Stephanie R Kadison; Taija Mäkinen; Rüdiger Klein; Mark Henkemeyer; Zaven Kaprielian
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

8.  EphA4 defines a class of excitatory locomotor-related interneurons.

Authors:  Simon J B Butt; Line Lundfald; Ole Kiehn
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

Review 9.  EphBs and ephrin-Bs: Trans-synaptic organizers of synapse development and function.

Authors:  Nathan T Henderson; Matthew B Dalva
Journal:  Mol Cell Neurosci       Date:  2018-07-19       Impact factor: 4.314

10.  The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.

Authors:  Melany J Wagner; Marilyn S Hsiung; Gerald D Gish; Rick D Bagshaw; Sasha A Doodnauth; Mohamed A Soliman; Claus Jørgensen; Monika Tucholska; Robert Rottapel
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.